The American Society for Clinical Oncology (ASCO) recommended eight different protein-related tumor markers for breast cancer: CA 15–13, CA 27–29, carcinoembryonic antigen, estrogen receptor (ER), progesterone receptor, human epidermal growth factor receptor 2 (HER2), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor (PAI)-1. This evidence concerns the gene PLAU and breast carcinoma.